申请人:E. R. Squibb & Sons, Inc.
公开号:US04689414A1
公开(公告)日:1987-08-25
Cardiovascular activity is exhibited by compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof, wherein R.sub.1 is alkyl, cycloalkyl, aryl, heterocyclo, --(CH.sub.2).sub.n --Y.sub.2, --(CH.sub.2).sub.p --Y.sub.3 or halo substituted alkyl; R.sub.2 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, --(CH.sub.2).sub.n --Y.sub.1, or halo substituted alkyl; R.sub.3 is hydrogen, alkyl, cycloalkyl, aryl, heterocyclo, --(CH.sub.2).sub.n --Y.sub.2, --(CH.sub.2).sub.p --Y.sub.3, or halo substituted alkyl; R.sub.4 is aryl or heterocyclo; R.sub.5 is hydrogen, alkyl, aryl, arylalkyl, cyano, nitro, ##STR2## Y.sub.1 is cycloalkyl, aryl, heterocyclo, hydroxyl, alkoxy, aryl-(CH.sub.2).sub.m --O--, mercapto, alkylthio, aryl-(CH.sub.2).sub.m --S--, amino, substituted amino, carbamoyl, ##STR3## Y.sub.2 is cycloalkyl, aryl, heterocyclo, carbamoyl, ##STR4## amino, or substituted amino; m is 0 or an integer of 1 to 6; n is an integer of 1 to 6; and p is an integer of 2 to 6.
具有以下式子及其药学上可接受的盐的化合物表现出心血管活性:##STR1## 其中,R.sub.1是烷基、环烷基、芳基、杂环烷基、--(CH.sub.2).sub.n --Y.sub.2、--(CH.sub.2).sub.p --Y.sub.3或卤代烷基;R.sub.2是氢、烷基、烯基、炔基、环烷基、芳基、--(CH.sub.2).sub.n --Y.sub.1或卤代烷基;R.sub.3是氢、烷基、环烷基、芳基、杂环烷基、--(CH.sub.2).sub.n --Y.sub.2、--(CH.sub.2).sub.p --Y.sub.3或卤代烷基;R.sub.4是芳基或杂环烷基;R.sub.5是氢、烷基、芳基、芳基烷基、氰基、硝基、##STR2## Y.sub.1是环烷基、芳基、杂环烷基、羟基、烷氧基、芳基-(CH.sub.2).sub.m --O--、巯基、烷硫基、芳基-(CH.sub.2).sub.m --S--、氨基、取代氨基、氨基甲酰基、##STR3## Y.sub.2是环烷基、芳基、杂环烷基、氨基甲酰基、##STR4## 氨基或取代氨基;m为0或1到6的整数;n为1到6的整数;p为2到6的整数。